Why Madrigal Pharmaceuticals Stock Is Crushing It Today
Shares of Madrigal Pharmaceuticals (MDGL 222.12%) had skyrocketed by 243.7% as of 11:11 a.m. ET on Monday. The huge gain came after the company announced positive results from a phase 3 clinical study evaluating its experimental drug resmetirom as a treatment for nonalcoholic steatohepatitis…#madrigalpharmaceuticals #nafld #nash #nas #fda #nonalcoholic #foodanddrugadministration (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2022 Category: Consumer Health News Source Type: news

Highlights in Obesity From ACG 2022 Highlights in Obesity From ACG 2022
Key updates in obesity management from ACG 2022 include risk factors for acute pancreatitis in patients taking GLP-1 receptor agonists and management of NAFLD, as reported by Dr Carolyn Newberry.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2022 Category: Consumer Health News Tags: None ReCAP Source Type: news

Do you wake up between the hours of 1 and 4? Doctors warn your liver could be at risk
Non-alcoholic fatty liver disease tends not to cause harm in the initial stages, but the long-term consequences of the disease are far from benign. (Source: Daily Express - Health)
Source: Daily Express - Health - December 7, 2022 Category: Consumer Health News Source Type: news

Man, 42, receives fatty liver diagnosis after 'severe' rash spreads to 50% of his body
Estimations put the prevalence of non-alcoholic fatty liver disease in psoriasis patients at 47 percent. (Source: Daily Express - Health)
Source: Daily Express - Health - November 30, 2022 Category: Consumer Health News Source Type: news

Bariatric Surgery Cuts CVD Risk in Patients With Obesity, NAFLD
WEDNESDAY, Nov. 23, 2022 -- Bariatric surgery is associated with a significant reduction in cardiovascular disease (CVD) risk among individuals with severe obesity and nonalcoholic fatty liver disease (NAFLD), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 23, 2022 Category: Pharmaceuticals Source Type: news

Poor NAFLD Outcomes With Increased VCTE-Measured Liver Stiffness Poor NAFLD Outcomes With Increased VCTE-Measured Liver Stiffness
A prospective cohort study showed that patients with progression to cirrhosis measured by vibration-controlled transient elastography had a nearly twofold greater risk for poor outcomes or death.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 21, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Weight-Loss Surgery Slashes Odds for Heart Attack in Very Obese People
The study participants were also affected by what's known as nonalcoholic fatty liver disease (NAFLD), which is often linked with obesity. (Source: WebMD Health)
Source: WebMD Health - November 16, 2022 Category: Consumer Health News Source Type: news

Weight-Loss Surgery Slashes Odds for Heart Attack in Very Obese People
WEDNESDAY, Nov. 16, 2022 -- Getting bariatric surgery may significantly help prevent heart attacks, strokes and angina in very obese people, a new study finds. The study participants were also affected by what ' s known as nonalcoholic fatty liver... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2022 Category: General Medicine Source Type: news

NAFLD Patients With Diabetes Have Higher Fibrosis Progression Rate NAFLD Patients With Diabetes Have Higher Fibrosis Progression Rate
Progression rates for people with NAFLD and diabetes were higher than those without diabetes, researchers found.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 12, 2022 Category: Endocrinology Tags: Internal Medicine News Source Type: news

Liver Disease –Related Deaths Rise During the Pandemic Liver Disease –Related Deaths Rise During the Pandemic
US mortality for alcohol-associated liver disease and nonalcoholic fatty liver disease increased at"alarming" rates during the COVID-19 pandemic, according to new study findings.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 12, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Extrahepatic Morbidities and Mortality of NAFLD Extrahepatic Morbidities and Mortality of NAFLD
This review explores the evidence of associations between NAFLD and risk of extrahepatic outcomes.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 11, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Risk for Advanced Fibrosis Examined for Relatives of NAFLD Patients
THURSDAY, Nov. 10, 2022 -- The risk for advanced fibrosis is increased for first-degree relatives of probands with nonalcoholic fatty liver disease (NAFLD) with advanced fibrosis, according to a study published online Nov. 1 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 10, 2022 Category: Pharmaceuticals Source Type: news

Higher Fibrosis Progression Rate in NAFLD Patients With Diabetes Higher Fibrosis Progression Rate in NAFLD Patients With Diabetes
Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2022 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Noninvasive Tests May Provide Prognostic Value in NAFLD Noninvasive Tests May Provide Prognostic Value in NAFLD
Fibrosis biomarkers were significantly predictive of event-free survival probability.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 8, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

NAFLD Progresses to Cirrhosis in Young and Old at Similar Rate NAFLD Progresses to Cirrhosis in Young and Old at Similar Rate
Risk factors for NAFLD vary with age, but all patients experience similar progression of advanced disease once it develops.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 1, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news